Skip to main content
Clinical Trials/CTRI/2024/12/077804
CTRI/2024/12/077804
Not yet recruiting
Phase 4

A comparative study to evaluate the clinical efficacy of Intravenous Paracetamol versus Intravenous Tramadol for postoperative pain in patients undergoing Laparoscopic Cholecystectomy. A Double Blind Randomized Control Trial.

Heritage Institute of Medical Sciences1 site in 1 country70 target enrollmentStarted: December 16, 2024Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Enrollment
70
Locations
1
Primary Endpoint
Intravenous paracetamol provides better management in postoperative pain in patients undergoing laparoscopic cholecystectomy.

Overview

Brief Summary

The study is a Double Blind Randomized Control Trial to evaluate the clinical efficacy of Intravenous Paracetamol versus Intravenous Tramadol for post-operative pain in patients undergoing Laparoscopic Cholecystectomy. in this study we will evaluate response to the drugs in term of reduction of pain at different time points i.e. before drug administration(T0), at 30th minute(T1), at 2nd hour(T2), at 4th hour(T3), at 8th hour(T4), at 16th hour(T5) and at 24th hour(T6) and will also compare the adverse effects of Intravenous Paracetamol versus Intravenous Tramadol.

Study Design

Study Type
Interventional
Allocation
Other
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • ASA grade I/II patients, Age between 18-60 years scheduled for elective laparoscopic cholecystectomy.

Exclusion Criteria

  • Patients who had history of allergy to paracetamol or tramadol, Patients with severe pain (VAS ≥ 5), Patients with significant coronary artery disease or ischemic myocardial disease, Patients with renal disease , liver disease , chronic lung disease and haemorrhagic conditions and/or coagulopathies, Patients with history of addiction to opioids or alcohol, Patient’s refusal.

Outcomes

Primary Outcomes

Intravenous paracetamol provides better management in postoperative pain in patients undergoing laparoscopic cholecystectomy.

Time Frame: Pain score before drug administration (T0), 30th minute (T1), 2nd hour (T2), 4th hour (T3), 8th hour (T4), 16th hour (T5), 24th hour (T6). | Haemodynamic parameters at 0 minute, 30 minutes, 2 hr, 4 hr, 8 hr, 16 hr, 24 hr.

Secondary Outcomes

  • Intravenous paracetamol has lesser side effects as compared to intravenous tramadol.

Investigators

Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Akash Maurya

Heritage Institute of Medical Sciences, Varanasi

Study Sites (1)

Loading locations...

Similar Trials